Tremelimumab plus Durvalumab in Unresectable Hepatocellular CarcinomaGhassan K. Abou‐Alfa, Bruno Sangro, Shukui Qin et al.|NEJM Evidence|2022Cited by 1.4k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Makoto Ueno et al.|The Lancet|2023Cited by 1k
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinomaBruno Sangro, Anthony B. El-Khoueiry, Ignacio Melero et al.|Journal of Hepatology|2020Cited by 421
SARS-CoV-2 infects human neural progenitor cells and brain organoidsBao‐Zhong Zhang, Jian‐Dong Huang, Hin Chu et al.|Cell Research|2020Cited by 336
Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patientsBao‐Zhong Zhang, Jian‐Dong Huang, Ye‐Fan Hu et al.|Cell Research|2020Cited by 122